HC Wainwright reiterated their buy rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a research note published on Wednesday, Benzinga reports. The brokerage currently has a $59.00 price target on the stock. HC Wainwright also issued estimates for Belite Bio’s Q2 2024 earnings at ($0.28) EPS, FY2024 earnings at ($1.09) EPS and […]
Belite Bio (NASDAQ:BLTE) Receives Overweight Rating from Cantor Fitzgerald
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Belite Bio (NASDAQ:BLTE) Stock Price Down 1 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.